Antibiotic prophylaxis in colorectal surgery [20]

New England Journal of Medicine

Volumn 356, Issue 16, 2007, Pages 1684-1685

  Moine, Pierre ^a   Asehnoune, Karim ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; ANTIINFECTIVE AGENT;

ANASTOMOSIS; ANTIBIOTIC PROPHYLAXIS; BACTEROIDES FRAGILIS; COLORECTAL SURGERY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ESCHERICHIA COLI; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBESITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; NOTE; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFOTETAN; COLORECTAL SURGERY; HUMANS; SURGICAL WOUND INFECTION;

EID: 34247198958     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070105     Document Type: Letter

References (5)

1. Martin C, Portet C, Lambert D, et al. Pharmacokinetics and tissue penetration of single-dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1992;36:1115-8.
2. Itani KMF, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006;355:2640-51.
3. Zelenitsky SA, Ariano RE, Harding GKM, Silverman RE. Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 2002;46:3026-30.
4. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-15.
5. Hoellman DB, Spangler SK, Jacobs MR, Appelbaum PC. In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds. Antimicrob Agents Chemother 1998;42:495-501.